Exelixis | Creditori Commerciali



Trade Creditors Cambiamento Data
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Amgen USD 2.41B 498M 2025-03
AstraZeneca 23.99B 1.44B 2025-06
Bayer EUR 6.59B 931M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Cytokinetics USD 13.94M 6.43M 2025-03
Eisai JPY 91.57B 27.04B 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Exelixis USD 25.82M 17.02M 2025-07
Genmab 5M 1.22M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 1.41B 1.21B 2025-06
Ionis Pharmaceuticals USD 22.8M 5.34M 2025-06
MacroGenics USD 5.01M 1.6M 2024-12
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.24B 393M 2025-03
Sanofi 7.55B 118M 2024-12
Takeda JPY 421.31B 54.23B 2025-06
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Xencor USD 16.19M 568K 2025-03


Exelixis Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.